Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00021073 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: alvocidib
DRUG: leucovorin calcium
DRUG: fluorouracil
DRUG: irinotecan hydrochloride

Sponsor

National Cancer Institute (NCI)